geoopen
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer
GEO Series GSE318308. Homo sapiens. 75 samples. Type: Expression profiling by high throughput sequencing.
ShareScore
12/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 4
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 4